 Clinical Study
May 29, 2024
TScan Therapeutics Receives FDA s RMAT Designation for Pioneering TCR-T Therapy Candidates TSC-100 and TSC-101 A Promising Leap Forward in the Treatment of Hematologic MalignanciesTScan Therapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Regenerative Medicine ...
|
Clinical Study
May 29, 2024
WALTHAM, Mass., May 29, 2024 The biopharmaceutical landscape anticipates significant insights as Invivyd, Inc. (Nasdaq: IVVD), a company fervently dedicated to combating serious viral infectious diseases, gears up to present preliminary data from its ongoing CANOPY Phase 3 clinical trial of VYD222 (pemivibart) at ...
|
Announcement
May 29, 2024
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024Thyroid eye disease (TED), also known as Graves ophthalmopathy, is an autoimmune condition that affects thousands of individuals worldwide. It is characterized by inflammation and swe...
|
|
 Management Announcement
May 29, 2024
In a strategic move aimed at optimizing resources and reducing costs, AEON Biopharma recently announced a reprioritization plan. The company expects its current cash and cash equivalents to be adequate to sustain corporate operations until the fourth quarter of 2024. Meanwhile, AEON Biopharma is actively evalua...
 Business Update
May 29, 2024
bluebird bio Strengthens Leadership Team with Appointment of O. James Sterling as Chief Financial Officer bluebird bio, Inc. (Nasdaq: BLUE), a pioneering gene therapy company, has announced the appointment of O. James Sterling as its Chief Financial Officer (CFO), effective June 10, 2024. This strategic move undersc...
|
|
Our most Popular Articles
|
Stocks on the Move
July 9, 2024
Nov Inc Underperforms Customers, But Shows Improvement in ROI: A Closer Look at the Events Impacting Nov Inc SharesNov Inc shares have had a challenging week, performing worse than its customers with a decline of 1.63%. Throughout this month, Nov Inc shares have been trailing the overall market performance. However,...
|
Merger and Acquisition
May 10, 2024
AGBA Group Holding Limited, the prominent financial supermarket in Hong Kong, has recently merged with Triller, marking a significant milestone in the company s mission to generate sustainable shareholder value. With over 1,500 dedicated employees, AGBA has consistently delivered steady growth, reinforcing...
|
Contract
February 28, 2024
Shift4, the renowned leader in integrated payments technology, has recently been chosen as the Official Point-of-Sale Systems Partner of the prestigious New York Yankees. This partnership is set to transform payment processing at Yankee Stadium in the Bronx and George M. Steinbrenner Field in Tampa. With its cutting...
|
|
|
Company News
|
Clinical Study
May 29, 2024
WALTHAM, Mass., May 29, 2024 The biopharmaceutical landscape anticipates significant insights as Invivyd, Inc. (Nasdaq: IVVD), a company fervently dedicated to combating serious viral infectious diseases, gears up to present preliminary data from its ongoing CANOPY Phase 3 clinical trial of VYD222 (pemivibart) at ...
|
Announcement
May 29, 2024
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024Thyroid eye disease (TED), also known as Graves ophthalmopathy, is an autoimmune condition that affects thousands of individuals worldwide. It is characterized by inflammation and swe...
|
Partnership
May 29, 2024
The biopharmaceutical industry has witnessed a groundbreaking collaboration between Foundation Medicine, Inc., a leading molecular information company, and PMV Pharmaceuticals, Inc., an innovative precision oncology company. This strategic partnership aims to develop a companion diagnostic for PMV Pharma s groundbre...
|
|
|
Company News
 Clinical Study
May 29, 2024
|
Company News
 Clinical Study
May 29, 2024
|
Company News
 Business Update
May 29, 2024
|
More Company News
|
Product Service News
May 29, 2024
|
Partnership
May 29, 2024
|
Announcement
May 29, 2024
|
Contract
May 29, 2024
|
Product Service News
May 29, 2024
|
Contract
May 29, 2024
|
Business Update
May 29, 2024
|
Business Update
May 29, 2024
|
Business Update
May 29, 2024
|
Business Update
May 29, 2024
|
|
|
|
Related News
|
Business Update
|
Business Update
|
|
Stocks
|
Business Update
|
Business Update
|
Business Update
|
|
|
|
Business News
|
 Management Announcement
In a strategic move aimed at optimizing resources and reducing costs, AEON Biopharma recently announced a reprioritization plan. The company expects its current cash and cash equivalents to be adequate to sustain corporate operations until the fourth quarter of 2024. Meanwhile, AEON Biopharma is actively evalua...
|
|
Business Update
bluebird bio Strengthens Leadership Team with Appointment of O. James Sterling as Chief Financial Officer bluebird bio, Inc. (Nasdaq: BLUE), a pioneering gene therapy company, has announced the appointment of O. James Sterling as its Chief Financial Officer (CFO), effective June 10, 2024. This strategic move undersc...
|
 Business Update
Breaking New Ground: Merck s Pioneering Efforts with KEYTRUDA and Financial Triumphs Highlighted Merck Takes a Leap with FDA s Priority Review for KEYTRUDA Plus Chemotherapy for Malignant Pleural Mesothelioma Merck & Co., Inc., known as MSD outside the United States and Canada, has once again set a benchmark in the...
|
 Management Changes
Washington, May 29, 2024 - FTI Consulting, Inc. (NYSE: FCN), a global business advisory firm, has announced the appointment of Michael Spadea as the Senior Managing Director and North America Leader of the Information Governance, Privacy and Security practice within the firm s Technology segment. This stra...
|
 Clinical Study
TScan Therapeutics Receives FDA s RMAT Designation for Pioneering TCR-T Therapy Candidates TSC-100 and TSC-101 A Promising Leap Forward in the Treatment of Hematologic MalignanciesTScan Therapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Regenerative Medicine ...
|
Our Most Popular Articles
|
 Stocks on the Move
Nov Inc Underperforms Customers, But Shows Improvement in ROI: A Closer Look at the Events Impacting Nov Inc SharesNov Inc shares have had a challenging week, performing worse than its customers with a decline of 1.63%. Throughout this month, Nov Inc shares have been trailing the overall market performance. However,...
|
 Merger and Acquisition
AGBA Group Holding Limited, the prominent financial supermarket in Hong Kong, has recently merged with Triller, marking a significant milestone in the company s mission to generate sustainable shareholder value. With over 1,500 dedicated employees, AGBA has consistently delivered steady growth, reinforcing...
|
 Contract
Shift4, the renowned leader in integrated payments technology, has recently been chosen as the Official Point-of-Sale Systems Partner of the prestigious New York Yankees. This partnership is set to transform payment processing at Yankee Stadium in the Bronx and George M. Steinbrenner Field in Tampa. With its cutting...
|
More News
|
 Clinical Study
WALTHAM, Mass., May 29, 2024 The biopharmaceutical landscape anticipates significant insights as Invivyd, Inc. (Nasdaq: IVVD), a company fervently dedicated to combating serious viral infectious diseases, gears up to present preliminary data from its ongoing CANOPY Phase 3 clinical trial of VYD222 (pemivibart) at ...
|
 Announcement
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024Thyroid eye disease (TED), also known as Graves ophthalmopathy, is an autoimmune condition that affects thousands of individuals worldwide. It is characterized by inflammation and swe...
|
 Partnership
The biopharmaceutical industry has witnessed a groundbreaking collaboration between Foundation Medicine, Inc., a leading molecular information company, and PMV Pharmaceuticals, Inc., an innovative precision oncology company. This strategic partnership aims to develop a companion diagnostic for PMV Pharma s groundbre...
|
 Clinical Study
New York and San Diego, May 29, 2024 - Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on discovering and developing innovative small molecule therapeutics to combat cancer, is excited to announce the appointment of Dr. Luke Walker to its Board of Directors. Dr. Walker, currently serving...
|
 Clinical Study
FDA Accepts Milestone Pharmaceuticals’ New Drug Application for CARDAMYST Nasal Spray for PSVT Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYSTMONTREAL and CHARLOTTE, N.C., May 29, 2024 Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company committed to...
|
|
Business Update
Arrowhead Pharmaceuticals, a California-based biopharmaceutical company, has recently presented new clinical data on two of its investigational RNAi-based medicines that show promising results in the treatment of mixed hyperlipidemia and inflammatory lung diseases such as asthma. The Phase 2b ARCHES-2 study of zodas...
|
 Product Service News
In today s fast-paced global market, providing exceptional customer service has become a key differentiating factor for businesses. One company that is leading the way in this regard is eGain, the pioneering AI knowledge platform for customer service. With its state-of-the-art generative AI and multi-lingual support...
|
 Partnership
Himax Technologies Invests in Obsidian Sensors to Revolutionize Next-Gen Thermal Imaging TechnologyTainan, Taiwan, and San Diego, May 29, 2024 - Himax Technologies, Inc. (Nasdaq: HIMX), a leading supplier and fabless manufacturer of display drivers and semiconductor products, recently announced its strategic investm...
|
 Announcement
Date: May 29, 2024Allot Ltd., a prominent global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, has announced the appointment of Mrs. Liat Nahum as its new Chief Financial Officer (CFO), effective from July 1, 2024. This move comes in the wake of t...
|
 Contract
Warmflow, an Irish family-owned home heating technology company, is set to enhance its digital capabilities and empower its employees through the implementation of the Plex Smart Manufacturing Platform from Rockwell Automation. By leveraging cloud-based Enterprise Resource Planning (ERP), Quality Management System (...
|
 Product Service News
VAALCO Energy s Successful Drilling Campaign Ignites Growth in the Canadian MarketHouston, May 29, 2024 - VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY), a leading independent energy company, has recently achieved significant milestones in its drilling campaign in Canada. The company proudly announced the successful comp...
|
 Contract
Under the terms of the agreement, eVolare, which is one of the largest helicopter and private jet operators in the United Kingdom, will acquire four Lilium Jets. The sale and purchase agreements, which are binding, include comprehensive delivery schedules, guarantees, and warranties, in addition to deposits and pre-...
|
 Business Update
Oshkosh Defense, a subsidiary of Oshkosh Corporation, recently secured a $108.9 million order from the U.S. Army to supply additional Family of Medium Tactical Vehicles A2 (FMTV A2) and trailers. This order not only supports the U.S. Army s modernization initiatives but also includes Foreign Military Sales (FMS) to international partners. The FMTV A2 is well-known for its versatility, reliability, and high performance, making it suitable for a wide range of missions.In addition, Oshkosh Corporation, a leading innovator of purpose-built vehicles and equipment, announced that it will showcase two electrified, route-based fleet vehicles at the 2024 ACT Expo in Las Vegas. The company has been at the forefront of electrifying purpose-built commercial fleet vehicles across various industries such as construction, fire apparatus, and airport ground support. This highlights Oshkosh s commitment to sustainability and reflects the growing demand for eco-friendly transportation solutions.
|
 Business Update
Forrester Announces Complete Agenda for CX Summit EMEA 2024: Exploring AI and Personalized Customer Experience In an era where customers demand highly personalized services that align seamlessly with their individual preferences and behaviors, the upcoming CX Summit EMEA 2024 promises to be a groundbreaking event. F...
|
 Business Update
Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) By Vancouver, British Columbia Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcome...
|
 Business Update
Equity Residential Outperforms Competitors with Strong Revenue Increase and ProfitabilityEquity Residential, a leading real estate investment trust (REIT) specializing in multifamily properties, has announced its operating update and strong financial performance. The company s President and CEO, Mark J. Parrell, alo...
|
|
|
|
|
